Mary Fisher, Chief Operating Officer at ACORDA THERAPEUTICS INC (ACOR), sold 7,500 shares at $19.32 ($144K) on 2007-04-02, disclosed to the SEC on 2007-04-03.
Scheduled sale ($144k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.96 | 600 | $11K | 7.9% |
| 2 | $18.97 | 100 | $2K | 1.3% |
| 3 | $18.98 | 100 | $2K | 1.3% |
| 4 | $19.03 | 500 | $10K | 6.6% |
| 5 | $19.05 | 600 | $11K | 8.0% |
| 6 | $19.06 | 300 |
| $6K |
| 4.0% |
| 7 | $19.07 | 100 | $2K | 1.3% |
| 8 | $19.08 | 600 | $11K | 8.0% |
| 9 | $19.09 | 600 | $11K | 8.0% |
| 10 | $19.11 | 400 | $8K | 5.3% |
| 11 | $19.12 | 100 | $2K | 1.3% |
| 12 | $19.13 | 200 | $4K | 2.7% |
| 13 | $19.14 | 1,100 | $21K | 14.7% |
| 14 | $19.15 | 200 | $4K | 2.7% |
| 15 | $19.17 | 100 | $2K | 1.3% |
| 16 | $19.19 | 400 | $8K | 5.3% |
| 17 | $19.28 | 123 | $2K | 1.7% |
| 18 | $19.30 | 455 | $9K | 6.1% |
| 19 | $19.32 | 45 | $869 | 0.6% |
| 20 | $19.35 | 200 | $4K | 2.7% |
| 21 | $19.37 | 477 | $9K | 6.4% |
| 22 | $19.45 | 200 | $4K | 2.7% |
| Total | $19.14 avg | 7,500 | $144K | 100% |
| Filing → |
| OVAS | BUY | 2015-09-11 | $101K | — | Filing → |
| ZLTQ | SELL | 2015-01-27 | $1.7M | — | Filing → |
| ACOR | SELL | 2007-07-05 | $133K | — | Filing → |